Folitrax 7.5mg Injection
Marketer
Ipca Laboratories Ltd
Salt Composition
Methotrexate (7.5mg)
Overview Folitrax 7.5mg Injection
Methotrexate 7.5mg Injection is a medication employed in the management of rheumatoid arthritis, mitigating further joint deterioration. It's also indicated for severe psoriasis, certain cancers, and Crohn's disease. Administration of Methotrexate 7.5mg Injection requires medical or nursing oversight; self-administration is strictly prohibited. It can be used alone or in conjunction with other therapies. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Adhere strictly to the prescribed regimen; improper use or overdose can lead to severe adverse reactions. Therapeutic benefits may take weeks or months to manifest; discontinue only under medical direction. Alcohol consumption should be avoided due to increased liver damage risk. Common side effects include abdominal discomfort, dyspepsia, anorexia, nausea, emesis, fatigue, alopecia, and thrombocytopenia. Folic acid supplementation may alleviate some of these. Report any persistent or worsening side effects. Preventive or mitigative strategies may be available. As a potent medication, serious adverse events are possible. It can compromise immune function and potentially affect blood, liver, or kidney health; regular blood monitoring is essential. Prior to commencing treatment, inform your doctor of pregnancy, gastrointestinal, hepatic, or renal issues, and any concurrent medications, especially anti-infectives. Significant drug interactions are possible; disclose all medications to your healthcare provider. This medication is contraindicated during pregnancy and breastfeeding due to potential fetal harm. Pregnancy and conception should be avoided by both partners for several months post-treatment. Pre- and during-treatment assessments may include blood work, imaging (e.g., X-rays), and physical examinations.
Primary Ingredients of Folitrax 7.5mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Folitrax 7.5mg Injection
Management of rheumatoid arthritis, psoriasis, cancer, and Crohn's disease.
Major Benefits of Folitrax 7.5mg Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strictly prohibited.
Common Side effects of Folitrax 7.5mg Injection:
- Abdominal pain
- Indigestion
- Loss of appetite
- Nausea
- Vomiting
- Tiredness
- Mouth sore
- Low blood platelets
- Hair loss
How to use Folitrax 7.5mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Folitrax 7.5mg Injection works:
Leflunomide 7.5mg injection, an immunosuppressive agent, modifies the body's immune response in rheumatoid arthritis and Crohn's disease, thereby lessening inflammation, pain, stiffness, and enhancing joint function. Its action in psoriasis involves curbing excessive skin cell proliferation. In oncology, it impedes cancer cell growth by inhibiting a key enzyme required for cellular replication.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Folitrax 7.5mg Injection requires careful consideration. Seek medical advice before combining them.
PregnancyUNSAFE
Administering Folitrax 7.5mg Injection during pregnancy poses a substantial risk. Pregnant individuals should consult their physician; research in animal and human subjects reveals considerable harm to the fetus.
Breast feedingUNSAFE
Administering Folitrax 7.5mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administration of Folitrax 7.5mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects manifest.
KidneyCAUTION
Patients with impaired kidney function should receive Folitrax 7.5mg Injection cautiously, potentially requiring dosage modification. Physician consultation is recommended. Kidney function should be regularly assessed during treatment with this medication.
LiverCAUTION
Patients with hepatic impairment should use Folitrax 7.5mg Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Folitrax 7.5mg Injection is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Folitrax 7.5mg Injection :
NA
Facts to Know About Folitrax 7.5mg Injection
| Label | Value |
|---|---|
| Chemical Category | Glutamate Derivative |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Methotrexate: An Antimetabolite |
3,018 People bought this recently